Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 110 articles:
HTML format
Text format



Single Articles


    October 2017
  1. BAUGHMAN RP, Shlobin OA
    Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  2. DEGANO B, Soumagne T, Delaye T, Berger P, et al
    Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  3. BOUCLY A, Cottin V, Nunes H, Jais X, et al
    Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  4. WEATHERALD J, Boucly A, Lau E, Godinas L, et al
    Are indexed values better for defining exercise pulmonary hypertension?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  5. MULLIN CJ, Hsu S, Amancherla K, Wand A, et al
    Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  6. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  7. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  8. OLSSON KM, Wiedenroth CB, Kamp JC, Breithecker A, et al
    Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  9. JOUNEAU S, Ballerie A, Kerjouan M, Demant X, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  10. SANGES S, Prevotat A, Fertin M, Terriou L, et al
    Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  11. KLOK FA, Hoeper MM
    Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    February 2017
  12. SCHERRER U, Verges S
    Sleep apnoea and pulmonary hypertension in high-altitude dwellers: more than an association?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  13. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  14. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    December 2016
  15. LATSHANG TD, Furian M, Aeschbacher SS, Ulrich S, et al
    Association between sleep apnoea and pulmonary hypertension in Kyrgyz highlanders.
    Eur Respir J. 2016 Dec 22. pii: 1601530. doi: 10.1183/13993003.01530-2016.
    PubMed     Text format     Abstract available


    November 2016
  16. RIOU M, Seferian A, Savale L, Chaumais MC, et al
    Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity.
    Eur Respir J. 2016;48:1517-1519.
    PubMed     Text format    


    October 2016
  17. EID-LIDT G, Gaspar J, Sandoval J, Gonzalez-Pacheco H, et al
    Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00910-2016. doi: 10.1183/13993003.00910-2016
    PubMed     Text format    


    September 2016

  18. "New potential diagnostic biomarkers for pulmonary hypertension." Svenja L. Tiede, Henning Gall, Oliver Dorr, Marina dos Santos Guilherme, Christian Troidl, Christoph Liebetrau, Sandra Voss, Robert Voswinckel, Ralph T. Schermuly, Werner Seeger, Friedr
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  19. LEVY M, Eyries M, Szezepanski I, Ladouceur M, et al
    Genetic analyses in a cohort of children with pulmonary hypertension.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00211-2016. doi: 10.1183/13993003.00211-2016.
    PubMed     Text format     Abstract available


    August 2016
  20. NAGARAJ C, Tang B, Nagy BM, Papp R, et al
    Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension.
    Eur Respir J. 2016 Aug 18. pii: ERJ-01814-2015. doi: 10.1183/13993003.01814-2015
    PubMed     Text format     Abstract available


  21. GAMEN E, Seeger W, Pullamsetti SS
    The emerging role of epigenetics in pulmonary hypertension.
    Eur Respir J. 2016 Aug 4. pii: ERJ-01714-2015. doi: 10.1183/13993003.01714-2015.
    PubMed     Text format     Abstract available



  22. ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016;48:E68.
    PubMed     Text format    


    July 2016
  23. PARPALEIX A, Amsellem V, Houssaini A, Abid S, et al
    Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Eur Respir J. 2016 Jul 13. pii: ERJ-01448-2015. doi: 10.1183/13993003.01448-2015
    PubMed     Text format     Abstract available


    June 2016
  24. HASSOUN PM, Nathan SD
    Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.
    Eur Respir J. 2016;47:1615-7.
    PubMed     Text format    


    May 2016
  25. GERGES M, Gerges C, Lang IM
    How to define pulmonary hypertension due to left heart disease.
    Eur Respir J. 2016 May 12. pii: ERJ-00432-2016. doi: 10.1183/13993003.00432-2016
    PubMed     Text format    


    April 2016
  26. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


  27. NEDER JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, et al
    Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01948-2015. doi: 10.1183/13993003.01948-2015
    PubMed     Text format    


  28. MATHAI SC, Ghofrani HA, Mayer E, Pepke-Zaba J, et al
    Quality of life in patients with chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-01626-2015. doi: 10.1183/13993003.01626-2015
    PubMed     Text format     Abstract available


  29. OLIVEIRA RK, Agarwal M, Tracy JA, Karin AL, et al
    Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics.
    Eur Respir J. 2016;47:1179-88.
    PubMed     Text format     Abstract available


    March 2016
  30. GODINAS L, Lau EM, Chemla D, Lador F, et al
    Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01678-2015. doi: 10.1183/13993003.01678-2015
    PubMed     Text format    


  31. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


    February 2016
  32. LAHM T
    Sex differences in pulmonary hypertension: are we cleaning up the mess?
    Eur Respir J. 2016;47:390-3.
    PubMed     Text format    


  33. TOSHNER M
    Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
    Eur Respir J. 2016;47:388-9.
    PubMed     Text format    


  34. MALENFANT S, Perros F
    beta-blockers in pulmonary arterial hypertension: generation might matter.
    Eur Respir J. 2016;47:682-4.
    PubMed     Text format    


  35. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  36. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  37. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  38. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


    January 2016
  39. KOVACS G, Avian A, Olschewski H
    Proposed new definition of exercise pulmonary hypertension decreases false positive cases.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01394-2015. doi: 10.1183/13993003.01394-2015.
    PubMed     Text format    


  40. QUILOT FM, Georges M, Favrolt N, Beltramo G, et al
    Pulmonary hypertension associated with ponatinib therapy.
    Eur Respir J. 2016 Jan 7. pii: ERJ-01110-2015. doi: 10.1183/13993003.01110-2015.
    PubMed     Text format    


  41. SOMMER N, Strielkov I, Pak O, Weissmann N, et al
    Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
    Eur Respir J. 2016;47:288-303.
    PubMed     Text format     Abstract available


    December 2015
  42. SABOOR F, Reckmann AN, Tomczyk CU, Peters DM, et al
    Nestin-expressing vascular wall cells drive development of pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00574-2015. doi: 10.1183/13993003.00574-2015
    PubMed     Text format     Abstract available


  43. GIRERD B, Montani D, Jais X, Eyries M, et al
    Genetic counselling in a national referral centre for pulmonary hypertension.
    Eur Respir J. 2015 Dec 23. pii: ERJ-00717-2015. doi: 10.1183/13993003.00717-2015
    PubMed     Text format     Abstract available



  44. "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)."
    Eur Respir J. 2015;46:1855-6.
    PubMed     Text format    


  45. SAVALE L, Chaumais MC, Sitbon O, Humbert M, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1851-3.
    PubMed     Text format    


  46. PRELLA M, Yerly P, Nicod LP, Aubert JD, et al
    Pulmonary arterial hypertension in patients treated with interferon.
    Eur Respir J. 2015;46:1849-51.
    PubMed     Text format    


    November 2015
  47. BARBERA JA, Blanco I
    Gaining insights into pulmonary hypertension in respiratory diseases.
    Eur Respir J. 2015;46:1247-50.
    PubMed     Text format    


    October 2015
  48. HUITEMA MP, Spee M, Vorselaars VM, Boerman S, et al
    Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
    Eur Respir J. 2015 Oct 22. pii: ERJ-01319-2015. doi: 10.1183/13993003.01319-2015
    PubMed     Text format    



  49. ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension.
    Eur Respir J. 2015;46:E58.
    PubMed     Text format    


  50. LAU EM, Tamura Y, McGoon MD, Sitbon O, et al
    The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress.
    Eur Respir J. 2015;46:879-82.
    PubMed     Text format    


    September 2015
  51. CHEMLA D, Lau EM, Papelier Y, Attal P, et al
    Pulmonary vascular resistance and compliance relationship in pulmonary hypertension.
    Eur Respir J. 2015 Sep 4. pii: ERJ-00741-2015. doi: 10.1183/13993003.00741-2015.
    PubMed     Text format     Abstract available


  52. NAEIJE R, Vonk Noordegraaf A, Kovacs G
    Exercise-induced pulmonary hypertension: at last!
    Eur Respir J. 2015;46:583-6.
    PubMed     Text format    


    August 2015
  53. GALIE N, Humbert M, Vachiery JL, Gibbs S, et al
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): E
    Eur Respir J. 2015 Aug 29. pii: ERJ-01032-2015. doi: 10.1183/13993003.01032-2015
    PubMed     Text format    


  54. BREWIS MJ, Church AC, Johnson MK, Peacock AJ, et al
    Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02307-2014. doi: 10.1183/13993003.02307-2014
    PubMed     Text format     Abstract available


  55. RAGHU G, Nathan SD, Behr J, Brown KK, et al
    Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
    Eur Respir J. 2015 Aug 6. pii: ERJ-01537-2014. doi: 10.1183/13993003.01537-2014.
    PubMed     Text format     Abstract available


  56. TIEDE SL, Gall H, Dorr O, Troidl C, et al
    New potential diagnostic biomarkers for pulmonary hypertension.
    Eur Respir J. 2015 Aug 6. pii: ERJ-00187-2015. doi: 10.1183/13993003.00187-2015.
    PubMed     Text format     Abstract available


  57. HASSOUN PM
    Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis?
    Eur Respir J. 2015;46:303-6.
    PubMed     Text format    


  58. FRANTZ RP
    Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm.
    Eur Respir J. 2015;46:299-302.
    PubMed     Text format    


    July 2015
  59. KUMAR N, Price LC, Montero MA, Dimopoulos K, et al
    Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
    Eur Respir J. 2015 Jul 23. pii: ERJ-00052-2015. doi: 10.1183/13993003.00052-2015
    PubMed     Text format    


    June 2015
  60. QUARCK R, Wynants M, Verbeken E, Meyns B, et al
    Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2015 Jun 25. pii: ERJ-00099-2014. doi: 10.1183/09031936.00009914.
    PubMed     Text format     Abstract available


  61. KOSANOVIC D, Luitel H, Dahal BK, Cornitescu T, et al
    Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis.
    Eur Respir J. 2015 Jun 25. pii: ERJ-00182-2015. doi: 10.1183/09031936.00018215.
    PubMed     Text format     Abstract available


  62. MANDERS E, Ruiter G, Bogaard HJ, Stienen GJ, et al
    Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension.
    Eur Respir J. 2015;45:1737-40.
    PubMed     Text format    


  63. ROBERTSON HT
    Dead space: the physiology of wasted ventilation.
    Eur Respir J. 2015;45:1704-16.
    PubMed     Text format     Abstract available


    May 2015
  64. HERVE P, Lau E, Sitbon O, Savale L, et al
    Criteria for diagnosis of exercise pulmonary hypertension.
    Eur Respir J. 2015 May 28. pii: ERJ-00219-2015.
    PubMed     Text format     Abstract available


    April 2015
  65. TAMURA Y, Kimura M, Takei M, Ono T, et al
    Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension.
    Eur Respir J. 2015 Apr 30. pii: ERJ-00449-2015.
    PubMed     Text format    


  66. TRIP P, Rain S, Handoko ML, van der Bruggen C, et al
    Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension.
    Eur Respir J. 2015 Apr 16. pii: ERJ-01567-2014.
    PubMed     Text format     Abstract available


  67. HUERTAS A, Tu L, Thuillet R, Le Hiress M, et al
    Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Eur Respir J. 2015;45:1066-80.
    PubMed     Text format     Abstract available


    March 2015
  68. PLOEGSTRA MJ, Berger RM
    What's the (end) point?
    Eur Respir J. 2015;45:854-5.
    PubMed     Text format    


  69. VENTETUOLO CE, Kawut SM
    What's the (end) point?
    Eur Respir J. 2015;45:853-4.
    PubMed     Text format    


  70. HOUSTON BA, Tedford RJ
    Stressing the stepchild: assessing right ventricular contractile reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:604-7.
    PubMed     Text format    


  71. SHARMA T, Lau EM, Choudhary P, Torzillo PJ, et al
    Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:700-8.
    PubMed     Text format     Abstract available


    February 2015
  72. FUKIHARA J, Kondoh Y, Taniguchi H, Kimura T, et al
    Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease.
    Eur Respir J. 2015 Feb 5. pii: ERJ-01303-2014.
    PubMed     Text format    


    January 2015
  73. MORRIS NR, Seale H, Harris J, Hall K, et al
    Serious adverse events during a 6-min walk test in patients with pulmonary hypertension.
    Eur Respir J. 2015 Jan 22. pii: ERJ-01469-2014.
    PubMed     Text format    


  74. NAEIJE R, Ghio S
    More on the right ventricle in pulmonary hypertension.
    Eur Respir J. 2015;45:33-5.
    PubMed     Text format    


  75. COURAND PY, Pina Jomir G, Khouatra C, Scheiber C, et al
    Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension.
    Eur Respir J. 2015;45:139-49.
    PubMed     Text format     Abstract available


    December 2014
  76. GUIHAIRE J, Haddad F, Noly PE, Boulate D, et al
    Right ventricular reserve in a piglet model of chronic pulmonary hypertension.
    Eur Respir J. 2014 Dec 10. pii: ERJ-00813-2014.
    PubMed     Text format     Abstract available


  77. DE PERROT M, Mayer E
    Chronic thromboembolic pulmonary hypertension: do we need a new definition?
    Eur Respir J. 2014;44:1401-3.
    PubMed     Text format    


    November 2014
  78. SIMONNEAU G, D'Armini AM, Ghofrani HA, Grimminger F, et al
    Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).
    Eur Respir J. 2014 Nov 13. pii: erj00871-2014.
    PubMed     Text format     Abstract available


  79. AUGER WR, Kim NH
    Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues.
    Eur Respir J. 2014;44:1121-2.
    PubMed     Text format    


    October 2014
  80. QUARCK R, Delcroix M
    Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?
    Eur Respir J. 2014;44:842-5.
    PubMed     Text format    


    September 2014
  81. HELD M
    Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency.
    Eur Respir J. 2014;44:821-2.
    PubMed     Text format    


  82. COTTIN V, Lorillou M, Khouatra C, Traclet J, et al
    Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency.
    Eur Respir J. 2014;44:819-21.
    PubMed     Text format    


    August 2014
  83. DORFMULLER P, Gunther S, Ghigna MR, Thomas de Montpreville V, et al
    Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.
    Eur Respir J. 2014 Aug 19. pii: erj01691-2013.
    PubMed     Text format     Abstract available


  84. NATHAN SD
    Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeeze.
    Eur Respir J. 2014;44:287-8.
    PubMed     Text format    


  85. NAEIJE R, D'Alto M
    Sex matters in pulmonary arterial hypertension.
    Eur Respir J. 2014;44:553-4.
    PubMed     Text format    


  86. MONNERET D
    Cytokines in pulmonary arterial hypertension: consider sensitivity when using multiplex technology.
    Eur Respir J. 2014;44:547-9.
    PubMed     Text format    


    July 2014
  87. ZABINI D, Heinemann A, Foris V, Nagaraj C, et al
    Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients.
    Eur Respir J. 2014 Jul 17. pii: erj01450-2013.
    PubMed     Text format     Abstract available


    June 2014
  88. LEVARGE BL, Pomerantsev E, Channick RN
    Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension.
    Eur Respir J. 2014 Jun 12. pii: erj02093-2013.
    PubMed     Text format     Abstract available


  89. MCGOON MD
    Upfront triple therapy for pulmonary arterial hypertension: is three a crowd or critical mass?
    Eur Respir J. 2014;43:1556-9.
    PubMed     Text format    


  90. SITBON O, Jais X, Savale L, Cottin V, et al
    Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
    Eur Respir J. 2014;43:1691-7.
    PubMed     Text format     Abstract available


  91. LAU EM, Abelson D, Dwyer N, Yu Y, et al
    Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis.
    Eur Respir J. 2014;43:1804-7.
    PubMed     Text format    


    May 2014
  92. NAEIJE R, Delcroix M
    Is the time constant of the pulmonary circulation truly constant?
    Eur Respir J. 2014;43:1541-2.
    PubMed     Text format    


  93. GRIGNOLA JC
    Is the time constant of the pulmonary circulation truly constant?
    Eur Respir J. 2014;43:1539-41.
    PubMed     Text format    


  94. MARTINOT JB, Guenard HJ
    TLNO/TLCO ratio is not the end of the road.
    Eur Respir J. 2014;43:1535-6.
    PubMed     Text format    


  95. HARBAUM L, Hennigs JK, Baumann HJ, Bokemeyer C, et al
    Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapy.
    Eur Respir J. 2014;43:1513-5.
    PubMed     Text format    


  96. FUKUI S, Ogo T, Morita Y, Tsuji A, et al
    Right ventricular reverse remodelling after balloon pulmonary angioplasty.
    Eur Respir J. 2014;43:1394-402.
    PubMed     Text format     Abstract available


  97. GHIO S, Morsolini M, Corsico A, Klersy C, et al
    Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy.
    Eur Respir J. 2014;43:1403-9.
    PubMed     Text format     Abstract available


  98. SHIRAI Y, Tamura Y, Yasuoka H, Satoh T, et al
    IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment.
    Eur Respir J. 2014;43:1516-9.
    PubMed     Text format    


  99. RAMOS RP, Ota-Arakaki JS, Alencar MC, Ferreira EV, et al
    Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:1510-2.
    PubMed     Text format    


  100. BOERRIGTER BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, et al
    Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects.
    Eur Respir J. 2014;43:1316-25.
    PubMed     Text format     Abstract available


    April 2014
  101. SOUZA R, Fernandes CJ, Hoeper MM
    Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:963-5.
    PubMed     Text format    


  102. TRIP P, Girerd B, Bogaard HJ, de Man FS, et al
    Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:1195-8.
    PubMed     Text format    


    March 2014
  103. HASSOUN PM
    Inflammation in pulmonary arterial hypertension: is it time to quell the fire?
    Eur Respir J. 2014;43:685-8.
    PubMed     Text format    


  104. CRACOWSKI JL, Chabot F, Labarere J, Faure P, et al
    Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:915-7.
    PubMed     Text format    


  105. KLINE JA, Watts J, Courtney D, Lee YY, et al
    Severe pulmonary embolism decreases plasma L-arginine.
    Eur Respir J. 2014;43:906-9.
    PubMed     Text format    


  106. HERESI GA, Aytekin M, Hammel JP, Wang S, et al
    Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:912-4.
    PubMed     Text format    


    February 2014
  107. MONTANI D, Girerd B, Gunther S, Riant F, et al
    Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy.
    Eur Respir J. 2014;43:641-3.
    PubMed     Text format    


  108. VENTETUOLO CE, Praestgaard A, Palevsky HI, Klinger JR, et al
    Sex and haemodynamics in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:523-30.
    PubMed     Text format     Abstract available


  109. PAULIN R, Meloche J, Courboulin A, Lambert C, et al
    Targeting cell motility in pulmonary arterial hypertension.
    Eur Respir J. 2014;43:531-44.
    PubMed     Text format     Abstract available


    August 2013
  110. RUTTENS D , Verleden SE, Goeminne PC, Poels K, et al
    Smoking resumption after lung transplantation: need for standardized screening and importance for long-term outcome.
    Eur Respir J. 2013.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: